Skip to main content
Clinical Trials/NCT03006289
NCT03006289
Unknown
Not Applicable

Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer

Lin Liao0 sites3,000 target enrollmentDecember 2016
ConditionsThyroid Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thyroid Cancer
Sponsor
Lin Liao
Enrollment
3000
Primary Endpoint
lipids
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid cancer. Screen for the risk factors that affect the incidence of thyroid cancer.

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
November 2017
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Lin Liao
Responsible Party
Sponsor Investigator
Principal Investigator

Lin Liao

chief of endocrinology department at Qianfoshan Hospital

Qianfoshan Hospital

Eligibility Criteria

Inclusion Criteria

  • patients undergone thyroid surgery
  • signed the informed consent

Exclusion Criteria

  • 1.patients with no surgery

Outcomes

Primary Outcomes

lipids

Time Frame: before the thyroid surgery

Secondary Outcomes

  • glucose(before the thyroid surgery)

Similar Trials